Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
transmembrane 6 superfamily member 2 | 0.638 | 0.462 | 3.6E-05 |
|
disease | 0.600 | limited | 0.955 | 66 | 1 | 2014 | 2020 | ||||||||
|
transmembrane 6 superfamily member 2 | 0.638 | 0.462 | 3.6E-05 |
|
disease | 0.320 | None | 1.000 | 2 | 1 | 2014 | 2017 | ||||||||
|
transmembrane 6 superfamily member 2 | 0.638 | 0.462 | 3.6E-05 |
|
disease | 0.310 | None | 1.000 | 2 | 1 | 2015 | 2016 | ||||||||
|
transmembrane 6 superfamily member 2 | 0.638 | 0.462 | 3.6E-05 |
|
disease | 0.310 | None | 1.000 | 2 | 1 | 2014 | 2015 | ||||||||
|
transmembrane 6 superfamily member 2 | 0.638 | 0.462 | 3.6E-05 |
|
disease | 0.140 | None | 0.800 | 5 | 1 | 2016 | 2018 | ||||||||
|
transmembrane 6 superfamily member 2 | 0.638 | 0.462 | 3.6E-05 |
|
disease | 0.100 | None | 0.958 | 24 | 1 | 2015 | 2020 | ||||||||
|
transmembrane 6 superfamily member 2 | 0.638 | 0.462 | 3.6E-05 |
|
disease | 0.100 | None | 1.000 | 12 | 1 | 2015 | 2019 | ||||||||
|
transmembrane 6 superfamily member 2 | 0.638 | 0.462 | 3.6E-05 |
|
disease | 0.100 | None | 1.000 | 11 | 1 | 2015 | 2019 | ||||||||
|
transmembrane 6 superfamily member 2 | 0.638 | 0.462 | 3.6E-05 |
|
group | 0.100 | None | 1.000 | 11 | 1 | 2015 | 2020 | ||||||||
|
transmembrane 6 superfamily member 2 | 0.638 | 0.462 | 3.6E-05 |
|
phenotype | 0.100 | None | 1.000 | 5 | 1 | 2015 | 2019 | ||||||||
|
transmembrane 6 superfamily member 2 | 0.638 | 0.462 | 3.6E-05 |
|
phenotype | 0.100 | None | 1.000 | 3 | 1 | 2015 | 2019 | ||||||||
|
transmembrane 6 superfamily member 2 | 0.638 | 0.462 | 3.6E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
transmembrane 6 superfamily member 2 | 0.638 | 0.462 | 3.6E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
transmembrane 6 superfamily member 2 | 0.638 | 0.462 | 3.6E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
transmembrane 6 superfamily member 2 | 0.638 | 0.462 | 3.6E-05 |
|
disease | 0.090 | None | 1.000 | 9 | 1 | 2015 | 2019 | ||||||||
|
transmembrane 6 superfamily member 2 | 0.638 | 0.462 | 3.6E-05 |
|
disease | 0.080 | None | 1.000 | 8 | 1 | 2015 | 2020 | ||||||||
|
transmembrane 6 superfamily member 2 | 0.638 | 0.462 | 3.6E-05 |
|
disease | 0.080 | None | 1.000 | 8 | 1 | 2015 | 2019 | ||||||||
|
transmembrane 6 superfamily member 2 | 0.638 | 0.462 | 3.6E-05 |
|
group | 0.080 | None | 1.000 | 8 | 1 | 2015 | 2019 | ||||||||
|
transmembrane 6 superfamily member 2 | 0.638 | 0.462 | 3.6E-05 |
|
disease | 0.060 | None | 0.833 | 6 | 1 | 2015 | 2018 | ||||||||
|
transmembrane 6 superfamily member 2 | 0.638 | 0.462 | 3.6E-05 |
|
disease | 0.060 | None | 1.000 | 6 | 1 | 2016 | 2019 | ||||||||
|
transmembrane 6 superfamily member 2 | 0.638 | 0.462 | 3.6E-05 |
|
disease | 0.040 | None | 1.000 | 4 | 1 | 2014 | 2019 | ||||||||
|
transmembrane 6 superfamily member 2 | 0.638 | 0.462 | 3.6E-05 |
|
disease | 0.040 | None | 1.000 | 4 | 1 | 2015 | 2019 | ||||||||
|
transmembrane 6 superfamily member 2 | 0.638 | 0.462 | 3.6E-05 |
|
disease | 0.040 | None | 0.750 | 4 | 0 | 2016 | 2020 | ||||||||
|
transmembrane 6 superfamily member 2 | 0.638 | 0.462 | 3.6E-05 |
|
group | 0.040 | None | 1.000 | 4 | 1 | 2018 | 2019 | ||||||||
|
transmembrane 6 superfamily member 2 | 0.638 | 0.462 | 3.6E-05 |
|
disease | 0.030 | None | 1.000 | 3 | 1 | 2015 | 2016 |